Chemed CorporationCHENYSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank64
3Y CAGR-3.1%
5Y CAGR-5.2%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-3.1%/yr
vs +3.8%/yr prior
5Y CAGR
-5.2%/yr
Consistent
Acceleration
-6.9pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM16.76%-12.3%
202419.10%+4.4%
202318.30%-0.7%
202218.43%-4.1%
202119.22%-12.1%
202021.88%+36.2%
201916.06%+1.0%
201815.90%+69.0%
20179.41%-31.1%
201613.66%-